INTERNATIONAL PATENT: INCYTE CORPORATION FILES APPLICATION FOR "ANTI-MUTANT CALRETICULIN (CALR) ANTIBODY-DRUG CONJUGATES AND USES THEREOF"

GENEVA, May 14 -- INCYTE CORPORATION (1801 Augustine Cut-OffWilmington, Delaware 19803) filed a patent application (PCT/US2024/053807) for "ANTI-MUTANT CALRETICULIN (CALR) ANTIBODY-DRUG CONJUGATES AND USES THEREOF" on Oct 31, 2024. With publication no. WO/2025/096716, the details related to the patent application was published on May 08, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): DIMATTEO, Darlise (1801 Augustine Cut-OffWilmington, Delaware 19803), RIOS-DORIA, Jonathan (1801 Augustine Cut-OffWilmington, Delaware 19803)

Abstract: Anti-mutant calreticulin (mutCALR) antibody-drug conjug...